cipramil 20mg tablets
lundbeck ltd - citalopram hydrobromide - oral tablet - 20mg
cipramil 40mg tablets
lundbeck ltd - citalopram hydrobromide - oral tablet - 40mg
clopixol 2mg tablets
lundbeck ltd - zuclopenthixol dihydrochloride - oral tablet - 2mg
anafranil
novartis pharmaceuticals uk limited - clomipramine hydrochloride 10 mg - coated tablet
anafranil
novartis pharmaceuticals uk limited - clomipramine hydrochloride 25 mg - coated tablet
dipyridamole 100mg tablets
accord-uk ltd - dipyridamole - oral tablet - 100mg
dipyridamole 25mg tablets
accord-uk ltd - dipyridamole - oral tablet - 25mg
anafranil sr tablet prolonged release
novartis ireland limited - clomipramine hydrochloride - prolonged-release tablet - clomipramine hydrochloride 75 milligram(s) - psychoanaleptics
bezalip
teva pharma (new zealand) limited - bezafibrate 200mg; bezafibrate 200mg - film coated tablet - 200 mg - active: bezafibrate 200mg excipient: colloidal silicon dioxide macrogols magnesium stearate maize starch microcrystalline cellulose opadry white polyvinyl alcohol purified talc sodium starch glycolate starch titanium dioxide active: bezafibrate 200mg excipient: colloidal silicon dioxide kaolin lactose monohydrate macrogols magnesium stearate maize starch methacrylic acid copolymer microcrystalline cellulose polysorbate 80 purified talc sodium citrate dihydrate sodium starch glycolate titanium dioxide - - primary hyperlipidaemia types iia, iib, iii, iv and v (fredrickson classification) corresponding to groups i, ii and iii of the european atherosclerosis society guidelines – when diet alone or improvements in lifestyle such as increased exercise or weight reduction do not lead to an adequate response. - secondary hyperlipidaemias, e.g. severe hypertriglyceridemias, when sufficient improvement does not occur after correction of the underlying disorder (e.g. diabetes mellitus).
baytril flavour tablets 15 mg
bayer limited - enrofloxacin - tablets - 15 mg/tablet - enrofloxacin - canine, feline - antibacterial